Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 129
of 7Next
1:

Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.

Avihingsanon A, Manosuthi W, Kantipong P, Chuchotaworn C, Moolphate S, Sakornjun W, Gorowara M, Yamada N, Yanai H, Mitarai S, Ishikawa N, Cooper DA, Phanuphak P, Burger D, Ruxrungtham K.

Antivir Ther. 2008;13(4):529-36.

PMID: 18672531 [PubMed - indexed for MEDLINE]

2:

Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.

Nunn AJ, Mwaba P, Chintu C, Mwinga A, Darbyshire JH, Zumla A; UNZA-UCLMS Project LUCOT Collaboration.

BMJ. 2008 Jul 10;337:a257. doi: 10.1136/bmj.a257.

PMID: 18617486 [PubMed - indexed for MEDLINE]

3:

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.

Prendergast A, Mphatswe W, Tudor-Williams G, Rakgotho M, Pillay V, Thobakgale C, McCarthy N, Morris L, Walker BD, Goulder P.

AIDS. 2008 Jul 11;22(11):1333-43.

PMID: 18580613 [PubMed - indexed for MEDLINE]

4:

A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa.

Pope DS, Deluca AN, Kali P, Hausler H, Sheard C, Hoosain E, Chaudhary MA, Celentano DD, Chaisson RE.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):190-5.

PMID: 18520677 [PubMed - indexed for MEDLINE]

5:

A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis.

Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K, Meydani SN, Fawzi WW.

J Infect Dis. 2008 Jun 1;197(11):1499-505.

PMID: 18471061 [PubMed - indexed for MEDLINE]

6:

Thalidomide (celgene corp).

Bruyn GA.

IDrugs. 1998 Aug;1(4):490-500.

PMID: 18465584 [PubMed - in process]

7:

REPORTING OF INFORMED CONSENT, STANDARD OF CARE AND POST-TRIAL OBLIGATIONS IN GLOBAL RANDOMIZED INTERVENTION TRIALS: A SYSTEMATIC SURVEY OF REGISTERED TRIALS.

Cohen ER, O'Neill JM, Joffres M, Upshur RE, Mills E.

Dev World Bioeth. 2008 Apr 28. [Epub ahead of print]

PMID: 18445072 [PubMed - as supplied by publisher]

8:

Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.

Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA.

Int Immunopharmacol. 2008 Jun;8(6):845-51. Epub 2008 Feb 29.

PMID: 18442788 [PubMed - indexed for MEDLINE]

10:

Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.

Swaminathan S, Padmapriyadarsini C, Sukumar B, Iliayas S, Kumar SR, Triveni C, Gomathy P, Thomas B, Mathew M, Narayanan PR.

Clin Infect Dis. 2008 Mar 15;46(6):946-9.

PMID: 18279043 [PubMed - indexed for MEDLINE]

11:

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.

Vaccine. 2008 Mar 4;26(10):1375-86. Epub 2008 Jan 14.

PMID: 18272264 [PubMed - indexed for MEDLINE]

12:

Fluoroquinolones for treating tuberculosis.

Ziganshina LE, Squire SB.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004795. Review.

PMID: 18254061 [PubMed - indexed for MEDLINE]

13:

Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects.

Ford SL, Chen YC, Lou Y, Borland J, Min SS, Yuen GJ, Shelton MJ.

Antimicrob Agents Chemother. 2008 Feb;52(2):534-8. Epub 2007 Dec 3.

PMID: 18056271 [PubMed - indexed for MEDLINE]

14:

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.

AIDS. 2007 Nov 30;21(18):2483-91.

PMID: 18025885 [PubMed - indexed for MEDLINE]

15:

Population differences in death rates in HIV-positive patients with tuberculosis.

Ciglenecki I, Glynn JR, Mwinga A, Ngwira B, Zumla A, Fine PE, Nunn A.

Int J Tuberc Lung Dis. 2007 Oct;11(10):1121-8.

PMID: 17945070 [PubMed - indexed for MEDLINE]

16:

Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.

Mohammed A, Myer L, Ehrlich R, Wood R, Cilliers F, Maartens G.

Int J Tuberc Lung Dis. 2007 Oct;11(10):1114-20.

PMID: 17945069 [PubMed - indexed for MEDLINE]

17:

Corticosteroids for tuberculous pleurisy.

Engel ME, Matchaba PT, Volmink J.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001876. Review.

PMID: 17943759 [PubMed - indexed for MEDLINE]

18:

HIV risk reduction in a nurse case-managed TB and HIV intervention among homeless adults.

Schumann A, Nyamathi A, Stein JA.

J Health Psychol. 2007 Sep;12(5):833-43.

PMID: 17855466 [PubMed - indexed for MEDLINE]

19:

Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi.

Tostmann A, Boeree MJ, Harries AD, Sauvageot D, Banda HT, Zijlstra EE.

Trop Med Int Health. 2007 Jul;12(7):852-5.

PMID: 17596252 [PubMed - indexed for MEDLINE]

20:

Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.

Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC; Byramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group.

Clin Infect Dis. 2007 Jul 15;45(2):241-9. Epub 2007 Jun 4.

PMID: 17578786 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 129
of 7Next